Xcout IntelANGLE plc
CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced cancer diagnostic products, serving markets across the United Kingdom, Europe, North America, and other international regions. Its core offerings include the Parsortix PC1 and PR1 systems, which are innovative medical devices engineered to capture and retrieve intact circulating tumor cells (CTCs) from patient blood. Specifically, the PC1 system is designed for metastatic breast cancer samples, facilitating subsequent user-validated downstream analysis. CelLBxHealth also provides the Portrait+ CTC Staining kit, a laboratory solution for the identification, characterization, and enumeration of epithelial and mesenchymal CTCs with high analytical sensitivity and specificity, alongside the CellKeep Slide technology for CTC harvesting. In addition to these products, the company delivers a suite of laboratory services, including CTC enrichment and liquid biopsy analysis. Specialized assays are also available, such as Portrait Flex for immunofluorescence-based identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition, Portrait PD-L1 for CTC evaluation, and bespoke custom CTC assays. Furthermore, CelLBxHealth plc has forged strategic alliances, including a partnership with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. for the application of its pan-cancer next-generation sequencing (NGS) panel.
Subscribe to see ANGLE plc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ANGLE plc at a glance
ANGLE plc is a medical devices company headquartered in Guildford, United States. Its most recent funding round raised $250,000 in February 2015. Xcout tracks 13 named people at ANGLE plc, including Peter Michael Collins (CEO & Director).
ANGLE plc leadership
- Peter Michael CollinsCEO & Director
- Christina DorrisChief Commercial Officer
- Lavanya SivapalanChief Scientific Officer
- Michelle MunsonChief of Staff
- Dr Jan GroenExecutive Chairman
- Sinéad ArmstrongFinance Director
7 more named people on record for ANGLE plc, with roles, board committees and tenure — see the full roster →
ANGLE plc funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
ANGLE plc competitors
A few of ANGLE plc's closest competitors — see the full list of competitors and alternatives →
AnchorDx is a public biotechnology company headquartered in Guangzhou, China, with additional research and production facilities in the United States. The company specializes in the development of advanced cancer screening and early diagnostic solutions utilizing genomic and molecular technologies. Their products target precision medicine and oncology markets globally.
NIOX Group Plc is a worldwide company dedicated to innovating, developing, and distributing medical devices that measure fractional exhaled nitric oxide (FeNO). A key product is the NIOX VERO system, an easily portable and non-invasive diagnostic tool designed for immediate, on-site patient use. This system includes a compact device alongside a suite of disposable items like sensors, individual mouthpieces, and breathing handles, all essential for quantifying FeNO levels in patients. The company, which was founded in 2006 and is headquartered in Oxford, United Kingdom, was formerly known as Circassia Group Plc until its renaming to NIOX Group Plc in September 2022.
LuminX Global, Inc. develops medical devices and diagnostic software for dentistry, specifically focusing on subgingival diagnostics for gum disease detection. Its flagship product, the LuminX Probe, uses sensor-based measurements and imaging technology to automate periodontal charting for dental professionals, hygienists, and periodontists.
BiBB Instruments AB is a medical technology company that develops and manufactures EndoDrill®, a patented series of motorized endoscopic biopsy instruments designed to improve cancer diagnostics. The system uses an electric rotating needle technology to obtain high-quality core tissue samples during ultrasound-guided endoscopic procedures for various cancers, including gastrointestinal, lung, and urological malignancies.
Tvaster Genkalp Pvt. Ltd. is a molecular diagnostics company established in May 2021 and headquartered in Chennai, Tamil Nadu. The company specializes in liquid biopsy, offering blood-based cancer diagnostic solutions.
MedicaMetrix develops medical devices for prostate health, specifically offering the ProstaMetrix platform to measure prostate volume and calculate Prostate Specific Antigen Density (PSAD) during routine clinical examinations. The company serves urologists and healthcare professionals by providing tools for the early detection and ongoing monitoring of prostate conditions such as prostate cancer and BPH.
Get ANGLE plc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ANGLE plc in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access